OverviewChartNewsTraderScreen

UniCredit Bonus Zert AMD 28.03.20.../  DE000HD41ZF4  /

EUWAX
2024-06-19  10:33:11 AM Chg.-2.16 Bid12:06:54 PM Ask12:06:54 PM Underlying Strike price Expiration date Option type
151.96EUR -1.40% 152.10
Bid Size: 300		 152.25
Ask Size: 300		 ADVANCED MIC.DEV. D... - - 2025-03-28 Call
GlobeNewswire 2:57 AM Opthea A$55.0m (US$36.9m¹) Retail Entitlement Offer Opens
GlobeNewswire 06-18 4DMT to Present Initial Interim 24-week Landmark Analysis from the 4D-150 Phase 2 PRISM Population E...
GlobeNewswire 06-18 EyePoint Pharmaceuticals to Host R&D Day on June 26, 2024
GlobeNewswire 06-17 D&H’s June 18 Hershey THREAD Technology Conference to Deliver AI-Readiness & Training
TeleTrader 06-17 Nasdaq opens higher with Nvidia at new record high
GlobeNewswire 06-14 Sharecare wins 22 Digital Health Awards in Spring 2024 competition
GlobeNewswire 06-14 GRANITESHARES HITS $6 BILLION AUM AS NVDL SURGES
GlobeNewswire 06-14 Opthea Successfully Completes Placement and Institutional Component of Entitlement Offer Raising A$1...
GlobeNewswire 06-13 Ocular Therapeutix™ Highlights Exceptional AXPAXLI™ SOL-1 Enrollment and Plans for Repeat Dosing Stu...
GlobeNewswire 06-13 Global High-Performance Computing Servers Market Size Projected to Reach $26 Billion By 2032
GlobeNewswire 06-12 Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at t...
GlobeNewswire 06-12 Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...
GlobeNewswire 06-12 Opthea Announces Placement and Partially Underwritten Entitlement Offer to Raise up to Approximately...
GlobeNewswire 06-11 Outlook Therapeutics® to Present at the Virtual Investor Pitch Conference
GlobeNewswire 06-11 Adverum Biotechnologies Announces Appointments of Dr. Rabia Gurses Ozden as Chief Medical Officer an...
GlobeNewswire 06-11 YieldMax™ Launches Option Income Strategy ETF on Snowflake (SNOW)
GlobeNewswire 06-10 AMD to Present at the UBS Women in Tech Summit
GlobeNewswire 06-10 SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in...
GlobeNewswire 06-08 4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion C...
GlobeNewswire 06-06 AMD to Present at the Nasdaq London Investor Conference
GlobeNewswire 06-05 Ocular Therapeutix® to Host Investor Day on June 13, 2024
GlobeNewswire 06-05 YieldMax™ ETFs Announces Monthly Distributions on MSTY (106.33%), NVDY (101.82%), CONY (84.85%), YBI...
GlobeNewswire 06-05 Micron Samples Next-Gen Graphics Memory for Gaming and AI
GlobeNewswire 06-04 Ocular Therapeutix® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 06-03 Coherent Appoints Jim Anderson as Chief Executive Officer